Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.03 USD | +2.70% | +21.00% | +87.80% |
Apr. 24 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
Apr. 24 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+87.80% | 1.4B | |
+33.43% | 690B | |
+26.43% | 546B | |
-5.12% | 358B | |
+19.59% | 323B | |
+4.89% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.26% | 161B |
- Stock Market
- Equities
- TARS Stock
- News Tarsus Pharmaceuticals, Inc.
- Tarsus Completes Enrollment for Phase 3 Trial of TP-03 to Treat Demodex Blepharitis; Secures $175 Million Credit Facility